Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wanqi Zhu

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Precision Radiation Oncology|April 23, 2026
Sodium glycididazole combined with definitive chemoradiotherapy for patients with esophageal squamous cell carcinoma: A multicenter randomized clinical trialXiaoling Li, Hanxi Zhao, Peng Xie, et al.
JAMA Dermatology|June 1, 2022
Efficacy of Epigallocatechin-3-Gallate in Preventing Dermatitis in Patients With Breast Cancer Receiving Postoperative Radiotherapy: A Double-Blind, Placebo-Controlled, Phase 2 Randomized Clinical TrialHanxi Zhao, Wanqi Zhu, Xianguang Zhao, et al.
International Journal of Cancer|March 21, 2026
Coronavirus disease 2019 infection reduces EGFR-TKI efficacy in non-small cell lung carcinoma: Real-world evidence from a multicenter propensity-matched cohortWenjie Tang, Xiaoxuan Hou, Li Li, et al.
BMC Cancer|April 17, 2024
Phase I/II clinical trial of efficacy and safety of EGCG oxygen nebulization inhalation in the treatment of COVID-19 pneumonia patients with cancerXiaoyan Yin, Wanqi Zhu, Xiaoyong Tang, et al.
International Immunopharmacology|February 8, 2024
Real-world outcomes of first-line maintenance therapy for recurrent or metastatic cervical cancer: A multi-center retrospective studyChen Peng, Xiaolin Li, Wenjie Tang, et al.
International Journal of Radiation Oncology, Biology, Physics|November 21, 2020
Erlotinib Versus Etoposide/Cisplatin With Radiation Therapy in Unresectable Stage III Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer: A Multicenter, Randomized, Open-Label, Phase 2 TrialLigang Xing, Gang Wu, Luhua Wang, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Precision Radiation Oncology|April 23, 2026
Sodium glycididazole combined with definitive chemoradiotherapy for patients with esophageal squamous cell carcinoma: A multicenter randomized clinical trialXiaoling Li, Hanxi Zhao, Peng Xie, et al.
JAMA Dermatology|June 1, 2022
Efficacy of Epigallocatechin-3-Gallate in Preventing Dermatitis in Patients With Breast Cancer Receiving Postoperative Radiotherapy: A Double-Blind, Placebo-Controlled, Phase 2 Randomized Clinical TrialHanxi Zhao, Wanqi Zhu, Xianguang Zhao, et al.
International Journal of Cancer|March 21, 2026
Coronavirus disease 2019 infection reduces EGFR-TKI efficacy in non-small cell lung carcinoma: Real-world evidence from a multicenter propensity-matched cohortWenjie Tang, Xiaoxuan Hou, Li Li, et al.
BMC Cancer|April 17, 2024
Phase I/II clinical trial of efficacy and safety of EGCG oxygen nebulization inhalation in the treatment of COVID-19 pneumonia patients with cancerXiaoyan Yin, Wanqi Zhu, Xiaoyong Tang, et al.
International Immunopharmacology|February 8, 2024
Real-world outcomes of first-line maintenance therapy for recurrent or metastatic cervical cancer: A multi-center retrospective studyChen Peng, Xiaolin Li, Wenjie Tang, et al.
International Journal of Radiation Oncology, Biology, Physics|November 21, 2020
Erlotinib Versus Etoposide/Cisplatin With Radiation Therapy in Unresectable Stage III Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer: A Multicenter, Randomized, Open-Label, Phase 2 TrialLigang Xing, Gang Wu, Luhua Wang, et al.
Pageof 4